Stockreport

Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Merit Medical Systems, Inc.  (MMSI) 
Last merit medical systems, inc. earnings: 4/23 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: merit.com/investors
PDF At 24 months, the target lesion primary patency (TLPP)1 was 41.7%At 24 months, the access circuit primary patency (ACPP)2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 [Read more]